vs

Side-by-side financial comparison of Dexcom (DXCM) and WHITE MOUNTAINS INSURANCE GROUP LTD (WTM). Click either name above to swap in a different company.

WHITE MOUNTAINS INSURANCE GROUP LTD is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.3× Dexcom). WHITE MOUNTAINS INSURANCE GROUP LTD runs the higher net margin — 52.1% vs 21.2%, a 30.9% gap on every dollar of revenue. On growth, WHITE MOUNTAINS INSURANCE GROUP LTD posted the faster year-over-year revenue change (348.0% vs 21.6%). Over the past eight quarters, WHITE MOUNTAINS INSURANCE GROUP LTD's revenue compounded faster (57.4% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

White Mountains Insurance Group is a diversified insurance and related financial services holding company based in Hamilton, Bermuda. Redomiciled from Delaware, United States, on October 25, 1999, the company conducts most of its business through its insurance subsidiaries and other affiliates.

DXCM vs WTM — Head-to-Head

Bigger by revenue
WTM
WTM
1.3× larger
WTM
$1.6B
$1.3B
DXCM
Growing faster (revenue YoY)
WTM
WTM
+326.4% gap
WTM
348.0%
21.6%
DXCM
Higher net margin
WTM
WTM
30.9% more per $
WTM
52.1%
21.2%
DXCM
Faster 2-yr revenue CAGR
WTM
WTM
Annualised
WTM
57.4%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
WTM
WTM
Revenue
$1.3B
$1.6B
Net Profit
$267.3M
$835.8M
Gross Margin
62.9%
97.1%
Operating Margin
25.6%
56.2%
Net Margin
21.2%
52.1%
Revenue YoY
21.6%
348.0%
Net Profit YoY
153.6%
741.0%
EPS (diluted)
$0.67
$325.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
WTM
WTM
Q1 26
$1.3B
Q4 25
$1.3B
$1.6B
Q3 25
$1.2B
$864.2M
Q2 25
$1.2B
$689.2M
Q1 25
$1.0B
$577.8M
Q4 24
$1.1B
$358.0M
Q3 24
$994.2M
$839.1M
Q2 24
$1.0B
$395.4M
Net Profit
DXCM
DXCM
WTM
WTM
Q1 26
$267.3M
Q4 25
$267.3M
$835.8M
Q3 25
$283.8M
$113.8M
Q2 25
$179.8M
$122.9M
Q1 25
$105.4M
$33.9M
Q4 24
$151.7M
$-130.4M
Q3 24
$134.6M
$179.0M
Q2 24
$143.5M
$-54.6M
Gross Margin
DXCM
DXCM
WTM
WTM
Q1 26
62.9%
Q4 25
62.9%
97.1%
Q3 25
60.5%
93.6%
Q2 25
59.5%
93.8%
Q1 25
56.9%
98.7%
Q4 24
58.9%
97.9%
Q3 24
59.7%
99.1%
Q2 24
62.4%
98.2%
Operating Margin
DXCM
DXCM
WTM
WTM
Q1 26
25.6%
Q4 25
25.6%
56.2%
Q3 25
20.1%
20.7%
Q2 25
18.4%
25.6%
Q1 25
12.9%
12.5%
Q4 24
17.0%
-33.7%
Q3 24
15.3%
28.5%
Q2 24
15.7%
-8.8%
Net Margin
DXCM
DXCM
WTM
WTM
Q1 26
21.2%
Q4 25
21.2%
52.1%
Q3 25
23.5%
13.2%
Q2 25
15.5%
17.8%
Q1 25
10.2%
5.9%
Q4 24
13.6%
-36.4%
Q3 24
13.5%
21.3%
Q2 24
14.3%
-13.8%
EPS (diluted)
DXCM
DXCM
WTM
WTM
Q1 26
$0.67
Q4 25
$0.67
$325.02
Q3 25
$0.70
$44.18
Q2 25
$0.45
$47.75
Q1 25
$0.27
$13.19
Q4 24
$0.37
$-50.98
Q3 24
$0.34
$69.68
Q2 24
$0.35
$-21.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
WTM
WTM
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
$837.0M
Stockholders' EquityBook value
$2.7B
$5.4B
Total Assets
$6.3B
$12.3B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
WTM
WTM
Q1 26
$917.7M
Q4 25
$917.7M
Q3 25
$1.8B
Q2 25
$1.2B
Q1 25
$904.9M
Q4 24
$606.1M
Q3 24
$621.2M
Q2 24
$939.2M
Total Debt
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
$837.0M
Q3 25
$870.4M
Q2 25
$694.6M
Q1 25
$676.1M
Q4 24
$562.5M
Q3 24
$544.9M
Q2 24
$530.2M
Stockholders' Equity
DXCM
DXCM
WTM
WTM
Q1 26
$2.7B
Q4 25
$2.7B
$5.4B
Q3 25
$2.7B
$4.8B
Q2 25
$2.6B
$4.6B
Q1 25
$2.3B
$4.5B
Q4 24
$2.1B
$4.5B
Q3 24
$2.0B
$4.6B
Q2 24
$2.4B
$4.4B
Total Assets
DXCM
DXCM
WTM
WTM
Q1 26
$6.3B
Q4 25
$6.3B
$12.3B
Q3 25
$7.5B
$12.3B
Q2 25
$7.3B
$11.8B
Q1 25
$6.8B
$11.0B
Q4 24
$6.5B
$9.9B
Q3 24
$6.4B
$10.3B
Q2 24
$6.8B
$10.2B
Debt / Equity
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
0.15×
Q3 25
0.18×
Q2 25
0.15×
Q1 25
0.15×
Q4 24
0.13×
Q3 24
0.12×
Q2 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
WTM
WTM
Operating Cash FlowLast quarter
$53.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.06×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
$294.0M
$53.9M
Q3 25
$659.9M
$359.3M
Q2 25
$303.0M
$177.5M
Q1 25
$183.8M
$-40.2M
Q4 24
$301.4M
$64.1M
Q3 24
$199.5M
$269.4M
Q2 24
$279.4M
$216.8M
Free Cash Flow
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
DXCM
DXCM
WTM
WTM
Q1 26
Q4 25
1.10×
0.06×
Q3 25
2.33×
3.16×
Q2 25
1.69×
1.44×
Q1 25
1.74×
-1.19×
Q4 24
1.99×
Q3 24
1.48×
1.51×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons